View Post

Vaccine may prevent progression of DCIS to breast cancer

In In The News by Barbara Jacoby

From: Researchers at Mayo Clinic received a $3.7 million grant from the U.S. Department of Defense to test a vaccine designed to establish lifelong immunity against the development of breast cancer in women with ductal carcinoma in situ. No methods exist to detect which of the 35% of ductal carcinoma in situ (DCIS) cases will progress to cancer if …